当前位置：首页 SCI 期刊医学 Biomarkers In Medicine(非官网)

Biomarkers In MedicineSCIE

国际简称：BIOMARK MED 参考译名：医学生物标志物

中科院分区
4区
CiteScore分区
Q2
JCR分区
Q3

基本信息：: ISSN：1752-0363; E-ISSN：1752-0371; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：ENGLAND; 出版商：Future Medicine Ltd.; 出版语言：English; 出版周期：Bimonthly; 出版年份：2007; 研究方向：医学-医学：研究与实验

评价信息：: 影响因子：1.9; H-index：37; CiteScore指数：3.8; SJR指数：0.481; SNIP指数：0.491

发文数据：: Gold OA文章占比：10.80%; 研究类文章占比：89.16%; 年发文量：83; 自引率：0.0454...; 开源占比：0.0984; 出版撤稿占比：0; 出版国人文章占比：0.32; OA被引用占比：0.1210...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Biomarkers In Medicine期刊介绍

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.

Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

期刊简介Biomarkers In Medicine期刊介绍

《Biomarkers In Medicine》自2007出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：较慢,6-12周
医学
MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Biomarkers In Medicine Cite Score数据

CiteScore：3.8
SJR：0.481
SNIP：0.491

学科类别	分区	排名	百分位
大类：Medicine 小类：Biochemistry (medical)	Q2	34 / 72	53%
大类：Medicine 小类：Drug Discovery	Q3	95 / 157	39%
大类：Medicine 小类：Clinical Biochemistry	Q3	75 / 117	36%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Biomarkers In Medicine 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验	4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Biomarkers In Medicine JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q3	127 / 189	33.1%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q3	131 / 189	30.95%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND169
USA63
Italy38
Turkey36
GERMANY (FED REP GER)19
Brazil18
England18
Iran17
Greece13
Spain11

本刊中国学者近年发表论文

1、Association of TLR4 and TLR9 gene polymorphisms with the risk and progression of cervical lesions in HPV-infected women
Author: Zhang, Chunlin; Yang, Zhiping; Luo, Ping; Ye, Mengxia; Gong, Ping; Gong, Quan; Mei, Bing

Journal: BIOMARKERS IN MEDICINE. 2022; Vol. 17, Issue 3, pp. 133-142. DOI: 10.2217/bmm-2022-0702
2、Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma
Author: Sun, Xiaoqing; Cao, Jianghua; Sun, Peng; Yang, Hang; Li, Huan; Ma, Wenjuan; Wu, Xianqiu; He, Xiaohua; Li, Jing; Li, Zhiming; Huang, Jiajia

Journal: BIOMARKERS IN MEDICINE. 2022; Vol. 17, Issue 3, pp. 143-158. DOI: 10.2217/bmm-2022-0764
3、Low expression of MEOX2 is associated with poor survival in patients with breast cancer
Author: Wang, Huxia; Tang, Yanan; Wang, Meixia; Zhao, Jing; Ding, Caixia; Yang, Xiaomin; Han, Pihua; Liu, Peijun

Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1161-1170. DOI: 10.2217/bmm-2022-0468
4、Association between CYP19A1 rs6493497 and rs936306 polymorphisms and depression susceptibility in the Chinese population
Author: Peng, Qiuju; Yan, Yuan; Yan, Huacheng; Xie, Guibo; Shi, Lei; Wen, Yuguan; Chang, Qingxian

Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1171-1179. DOI: 10.2217/bmm-2022-0370
5、Novel nomogram for predicting coronary vulnerable plaque risk in patients with coronary artery disease
Author: Liu, Tao; Ji, Hanhua; Jian, Xinwen; Wang, Weiyi; Fan, Zeyuan

Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1139-1149. DOI: 10.2217/bmm-2022-0855
6、Novel biomarker panel for the diagnosis and prognosis assessment of sepsis based on machine learning
Author: Wu, Juehui; Liang, Jianbo; An, Shu; Zhang, Jingcong; Xue, Yimin; Zeng, Yanlin; Li, Laisheng; Luo, Jinmei

Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 15, pp. 1129-1138. DOI: 10.2217/bmm-2022-0433
7、3 ' untranslated region variants in DEFA5 gene associated with susceptibility to IgA nephropathy in the Chinese Han population
Author: Peng, Hongwei; Fan, Pingyun; Hong, Yifen; He, Jing; Zeng, Xiangxiu; Xu, Fengguo; Zhao, Yunxia; Jin, Tianbo

Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1151-1159. DOI: 10.2217/bmm-2022-0518
8、Linkage of calprotectin with inflammation, activity and treatment response of rheumatoid arthritis: a meta-analysis
Author: Zeng, Jiashun; Liu, Xiaoxia; Liu, Jun; Wu, Pengjia; Yang, Lei

Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 17, pp. 1239-1249. DOI: 10.2217/bmm-2022-0216